A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma

Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

NCT06033833 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

NCT04718103 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma

NCT00267202 ·Status: COMPLETED ·Phase: PHASE4

Study of TNFR:Fc (Enbrel) in the Treatment of Asthma

NCT00001893 ·Status: COMPLETED ·Phase: PHASE2

A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma

NCT05584306 ·Status: UNKNOWN ·Phase: PHASE1

A Study of CM310 in Subjects With Moderate to Severe Asthma

NCT05186909 ·Status: COMPLETED ·Phase: PHASE2

A 12-Week Study in Adult Subjects With Asthma

NCT01516086 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma

NCT00046748 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma

NCT01508936 ·Status: COMPLETED ·Phase: PHASE3

A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma

NCT00983658 ·Status: COMPLETED ·Phase: PHASE2

Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma

NCT05036733 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics

NCT00150397 ·Status: COMPLETED ·Phase: PHASE2

A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma

NCT04007198 ·Status: COMPLETED ·Phase: PHASE1

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)

NCT01656395 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma

NCT03782532 ·Status: COMPLETED ·Phase: PHASE3

TNF-alpha Directed Therapy in Asthma

NCT00278083 ·Status: COMPLETED ·Phase: PHASE2

A Study of ARRY-502 in Patients With Persistent Asthma

NCT01561690 ·Status: COMPLETED ·Phase: PHASE2

A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma

NCT06680947 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled Asthma

NCT02099656 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

NCT00670930 ·Status: COMPLETED ·Phase: PHASE4

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

NCT05757102 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype

NCT05522439 ·Status: COMPLETED ·Phase: PHASE2

Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

NCT04719832 ·Status: COMPLETED ·Phase: PHASE3

A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma

NCT00207740 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma

NCT02105012 ·Status: COMPLETED ·Phase: PHASE2